Concurrent temozolomide and radiation as the initial treatment for anaplastic glioma.

被引：0
|
作者：
Tham, C. K.
See, S.
Tan, S. H.
Ng, W. H.
Lim, K. H. C.
Thomas, J.
Chua, E. T.
机构：
[1] Natl Canc Ctr, Singapore, Singapore
[2] Natl Inst Neurosci, Singapore, Singapore
[3] Natl Univ Singapore Hosp, Singapore 117548, Singapore
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.2051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2051
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combined temozolomide and radiation as an initial treatment for anaplastic glioma
    Tham, Chee Kian
    See, Siew Ju
    Tan, Sze Huey
    Lim, Keith Hsiu Chin
    Ng, Wai Hoe
    Thomas, John
    Chong, Dawn Qingqing
    Chua, Eu Tiong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (03) : 220 - 225
  • [2] Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide
    McTyre, E.
    Lucas, J. T., Jr.
    Helis, C.
    Farris, M.
    Houseknecht, K.
    Mott, R.
    Laxton, A. W.
    Tatter, S. B.
    Lesser, G. J.
    Chan, M. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E108 - E108
  • [3] Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide
    McTyre, Emory
    Lucas, John T.
    Helis, Corbin
    Farris, Michael
    Soike, Michael
    Mott, Ryan
    Laxton, Adrian W.
    Tatter, Stephen B.
    Lesser, Glenn J.
    Strowd, Roy E.
    Lo, Hui-Wen
    Debinski, Waldemar
    Chan, Michael D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 813 - 819
  • [4] Temozolomide in the treatment of progressive low-grade glioma.
    Silva, NS
    Paes, V
    Galeana, J
    Pascalicchio, AP
    Galväo, C
    Cavalheiro, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 806S - 806S
  • [5] Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma
    Yang, Pei
    Zhang, Chuanbao
    Cai, Jinquan
    You, Gan
    Wang, Yinyan
    Qiu, Xiaoguang
    Li, Shouwei
    Wu, Chenxing
    Yao, Kun
    Li, Wenbin
    Peng, Xiaoxia
    Zhang, Wei
    Jiang, Tao
    ONCOTARGET, 2016, 7 (48) : 80091 - 80100
  • [6] Anaplastic glioma: benefit of temozolomide clarified
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (07) : 399 - 399
  • [7] Phase I study of sorafenib in combination with radiation therapy and temozolomide for the first-line treatment of patients with high grade glioma.
    Hottinger, A. F.
    Ben Aissa, A.
    Bodmer, A.
    Squiban, D.
    Dunkel, N.
    Maradan, N.
    Vargas, M. I.
    Weber, D. C.
    Brendel, E.
    Dietrich, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Secondary hematologic malignancies associated with temozolomide (TMZ) in patients with glioma.
    Momota, H.
    Narita, Y.
    Miyakita, Y.
    Shibui, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Anaplastic glioma. Neuropathology, molecular diagnostics and current study concepts
    Wick W.
    Weller M.
    Der Nervenarzt, 2010, 81 (8) : 928 - 935
  • [10] Immunotherapy as treatment for dogs with glioma.
    Goulart, Michelle
    Pluhar, Elizabeth
    Andersen, Brian
    Seiler, Charles
    Hunt, Matthew
    O'Sullivan, Gerry
    Zhang, Zoe
    Ohlfest, John
    CANCER RESEARCH, 2013, 73
12345